IPA is a leading brand in the field of bioplatform-based antibody discovery. With their team of experts in the science and business of biotechnology, they are ranked as the number one CRO (Contract Research Organization). Their main goal is to engineer success in clinical trials and accelerate the race towards clinical efficacy.

IPA offers a wide range of products and services to support antibody discovery, including target analysis, immunization, and antibody characterization. They also provide preclinical services and protein manufacturing capabilities. What sets IPA apart is their innovative AI technology called LENS ai, which enhances their antibody discovery process.

This technology translates massive amounts of data into meaningful knowledge, revolutionizing biotherapeutic science. IPA is constantly at the forefront of industry advancements and actively participates in various events and conferences to share their insights. With their HUB of Biotherapeutic Intelligence™, IPA is dedicated to revolutionizing antibody research and helping their pharmaceutical partners conquer deadly diseases